Splice Bio

About:

Splice Bio is a biotech company based on intein technologies developed in the Muir Lab at Princeton University.

Website: https://splice.bio/

Twitter/X: ProteoDesignHQ

Top Investors: Asabys Partners, New Enterprise Associates, Novartis Venture Fund, Gilde Healthcare, Ysios Capital

Description:

Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations of adeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.